microRNA-based cancer cell reprogramming technology (Review)
- Authors:
- Shimpei Nishikawa
- Hideshi Ishii
- Naotsugu Haraguchi
- Yoshihiro Kano
- Takahito Fukusumi
- Katsuya Ohta
- Miyuki Ozaki
- Dyah Laksmi Dewi
- Daisuke Sakai
- Taroh Satoh
- Hiroaki Nagano
- Yuichiro Doki
- Masaki Mori
-
Affiliations: Department of Frontier Science for Cancer and Chemotherapy, Osaka University, Graduate School of Medicine, Suita, Osaka 565-0871, Japan, Department of Gastroenterological Surgery, Osaka University, Graduate School of Medicine, Suita, Osaka 565-0871, Japan - Published online on: April 23, 2012 https://doi.org/10.3892/etm.2012.558
- Pages: 8-14
This article is mentioned in:
Abstract
Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI | |
John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol. 2:e3632004. View Article : Google Scholar | |
Houbaviy HB, Murray MF and Sharp PA: Embryonic stem cell-specific microRNAs. Dev Cell. 5:351–358. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lim LP, Glasner ME, Yekta S, Burge CB and Bartel DP: Vertebrate microRNA genes. Science. 299:15402003. View Article : Google Scholar : PubMed/NCBI | |
Leung AK and Sharp PA: MicroRNA functions in stress responses. Mol Cell. 40:205–215. 2010. View Article : Google Scholar : PubMed/NCBI | |
Marsit CJ, Eddy K and Kelsey KT: MicroRNA responses to cellular stress. Cancer Res. 66:10843–10848. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ng HH and Surani MA: The transcriptional and signalling networks of pluripotency. Nat Cell Biol. 13:490–496. 2011. View Article : Google Scholar : PubMed/NCBI | |
Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI | |
Calin GA, Ferracin M, Cimmino A, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005. View Article : Google Scholar : PubMed/NCBI | |
Cerchia L and De Franciscis V: Noncoding RNAs in cancer medicine. J Biomed Biotechnol. 2006:1–8. 2006. View Article : Google Scholar | |
Cummins JM, He Y, Leary RJ, et al: The colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692. 2006. View Article : Google Scholar : PubMed/NCBI | |
Wijnhoven B, Michael MZ and Watson DI: MicroRNAs and cancer. Br J Surg. 94:23–30. 2007. View Article : Google Scholar | |
Davis RL, Weintraub H and Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987–1000. 1987. View Article : Google Scholar : PubMed/NCBI | |
Xie H, Ye M, Feng R and Graf T: Stepwise reprogramming of B cells into macrophages. Cell. 117:663–676. 2004. View Article : Google Scholar : PubMed/NCBI | |
Zhou Q, Brown J, Kanarek A, Rajagopal J and Melton DA: In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 455:627–632. 2008. View Article : Google Scholar : PubMed/NCBI | |
French SW, Hoyer KK, Shen RR and Teitell MA: Transdifferentiation and nuclear reprogramming in hematopoietic development and neoplasia. Immunol Rev. 187:22–39. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ungefroren H and Fändrich F: The programmable cell of monocytic origin (PCMO): a potential adult stem/progenitor cell source for the generation of islet cells. Adv Exp Med Biol. 654:667–682. 2010.PubMed/NCBI | |
Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI | |
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131:861–872. 2007. View Article : Google Scholar | |
Yamanaka S: Elite and stochastic models for induced pluripotent stem cell generation. Nature. 460:49–52. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar | |
McKenna ES and Roberts CW: Epigenetics and cancer without genomic instability. Cell Cycle. 8:23–26. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
Rodríguez-Paredes M and Esteller M: Cancer epigenetics reaches mainstream oncology. Nat Med. 17:330–339. 2011. | |
Cavenee W, Dryja TP, Phillips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:779–784. 1983. View Article : Google Scholar : PubMed/NCBI | |
Weinberg R: Tumor suppressor genes. Science. 254:1138–1146. 1991. View Article : Google Scholar : PubMed/NCBI | |
Weinberg RA: The retinoblastoma protein and cell cycle control. Cell. 81:323–330. 1995. View Article : Google Scholar : PubMed/NCBI | |
Wang JY: Cellular responses to DNA damage. Curr Opin Cell Biol. 10:240–247. 1998. View Article : Google Scholar : PubMed/NCBI | |
Solinas G, Marchesi F, Garlanda C, Mantovani A and Allavena P: Inflammation-mediated promotion of invasion and metastasis. Cancer Metastasis Rev. 29:243–248. 2010. View Article : Google Scholar : PubMed/NCBI | |
Vogelstein B and Kinzler KW: The multistep nature of cancer. Trends Genet. 9:138–141. 1993. View Article : Google Scholar : PubMed/NCBI | |
Bonavia R, Inda MD, Cavenee WK and Furnari FB: Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 71:4055–4060. 2011. View Article : Google Scholar : PubMed/NCBI | |
Miyoshi N, Ishii H, Nagai K, et al: Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA. 107:40–45. 2010. View Article : Google Scholar : PubMed/NCBI | |
Friedlander SYG, Chu GC, Snyder EL, et al: Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell. 16:379–389. 2009. View Article : Google Scholar : PubMed/NCBI | |
Orkin SH and Hochedlinger K: Chromatin connections to pluripotency and cellular reprogramming. Cell. 145:835–850. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gurdon JB and Wilmut I: Nuclear transfer to eggs and oocytes. Cold Spring Harb Perspect Biol. 3:1–14. 2011. View Article : Google Scholar | |
Maekawa M, Yamaguchi K, Nakamura T, et al: Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature. 474:225–229. 2011. View Article : Google Scholar : PubMed/NCBI | |
Nilsen TW: Endo-siRNAs: Yet another layer of complexity in RNA silencing. Nat Struct Mol Biol. 15:546–548. 2008. View Article : Google Scholar : PubMed/NCBI | |
Golden DE, Gerbasi VR and Sontheimer EJ: An inside job for siRNAs. Mol Cell. 31:309–312. 2008. View Article : Google Scholar : PubMed/NCBI | |
Okamura K and Lai EC: Endogenous small interfering RNAs in animals. Nat Rev Mol Cell Biol. 9:673–678. 2008. View Article : Google Scholar : PubMed/NCBI | |
Suh N and Blelloch R: Small RNAs in early mammalian development: from gametes to gastrulation. Development. 138:1653–1661. 2011. View Article : Google Scholar : PubMed/NCBI | |
Watanabe T, Totoki Y, Toyoda A, et al: Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature. 453:539–543. 2008. View Article : Google Scholar : PubMed/NCBI | |
Watanabe T, Tomizawa S, Mitsuya K, et al: Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science. 332:848–852. 2011. View Article : Google Scholar : PubMed/NCBI | |
Song R, Hennig GW, Wu Q, Jose C, Zheng H and Yan W: Male germ cells express abundant endogenous siRNAs. Proc Natl Acad Sci USA. 108:13159–13164. 2011. View Article : Google Scholar : PubMed/NCBI | |
Suh N, Baehner L, Moltzahn F, Melton C, Shenoy A, Chen J and Blelloch R: MicroRNA function is globally suppressed in mouse oocytes and early embryos. Curr Biol. 20:271–277. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ma J, Flemr M, Stein P, et al: MicroRNA activity is suppressed in mouse oocytes. Curr Biol. 20:265–270. 2010. View Article : Google Scholar : PubMed/NCBI | |
Anokye-Danso F, Trivedi CM, Juhr D, et al: Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 8:376–388. 2011. View Article : Google Scholar : PubMed/NCBI | |
Miyoshi N, Ishii H, Nagano H, et al: Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 8:633–638. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT and Ying SY: Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 14:2115–2124. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lin SL, Chang DC, Ying SY, Leu D and Wu DT: MicroRNA miR-302 inhibits the tumorigenicity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 70:9473–9482. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sozzi G, Huebner K and Croce CM: FHIT in human cancer. Adv Cancer Res. 74:141–166. 1998. View Article : Google Scholar | |
Huebner K and Croce CM: FRA3B and other common fragile sites: the weakest link. Nat Rev Cancer. 1:214–221. 2001. View Article : Google Scholar : PubMed/NCBI | |
Arlt MF, Casper AM and Glover TW: Common fragile sites. Cytogenet Genome Res. 100:92–100. 2003. View Article : Google Scholar | |
Cimprich KA: Fragile sites: breaking up over a slowdown. Curr Biol. 13:R231–R233. 2003. View Article : Google Scholar : PubMed/NCBI | |
Durkin SG and Glover TW: Chromosome fragile sites. Annu Rev Genet. 41:169–192. 2007. View Article : Google Scholar | |
Sutherland GR: Rare fragile sites. Cytogenet Genome Res. 100:77–84. 2003. View Article : Google Scholar | |
Croce CM, Sozzi G and Huebner K: Role of FHIT in human cancer. J Clin Oncol. 17:1618–1624. 1999.PubMed/NCBI | |
Dillon LW, Burrow AA and Wang YH: DNA instability at chromosomal fragile sites in cancer. Curr Genomics. 11:326–337. 2010. View Article : Google Scholar : PubMed/NCBI | |
Casper AM, Nghiem P, Arlt MF and Glover TW: ATR regulates fragile site stability. Cell. 111:779–789. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cirombella R, Montrone G, Stoppacciaro A, et al: Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation. Cancer Lett. 291:230–236. 2010. View Article : Google Scholar : PubMed/NCBI | |
Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hu B, Wang H, Wang X, et al: Fhit and CHK1 have opposing effects on homologous recombination repair. Cancer Res. 65:8613–8616. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ishii H, Mimori K, Inoue H, et al: Fhit modulates the DNA damage checkpoint response. Cancer Res. 66:11287–11292. 2006. View Article : Google Scholar : PubMed/NCBI | |
Okumura H, Ishii H, Pichiorri F, Croce CM, Mori M and Huebner K: Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Sci. 100:1145–1150. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ishii H, Mimori K, Ishikawa K, et al: Fhit-deficient hematopoietic stem cells survive hydroquinone treatment long-term, carrying precancerous alterations. Cancer Res. 68:3662–3670. 2008. View Article : Google Scholar : PubMed/NCBI | |
Rossi S, Sevignani C, Nnadi SC, Siracusa LD and Calin GA: Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome. 19:526–540. 2008. View Article : Google Scholar : PubMed/NCBI | |
Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S and Sarkar FH: Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat. 13:109–118. 2010. View Article : Google Scholar : PubMed/NCBI | |
Zimmerman AL and Wu S: MicroRNAs, cancer and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar : PubMed/NCBI | |
Cortez MA, Ivan C, Zhou P, Wu X, Ivan M and Calin GA: microRNAs in cancer: from bench to bedside. Adv Cancer Res. 108:113–157. 2010. View Article : Google Scholar : PubMed/NCBI | |
Garzon R, Marcucci G and Croce CM: Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI | |
White NM, Fatoohi E, Metias M, Jung K, Stephan C and Yousef GM: Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol. 8:75–84. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kasemeier-Kulesa JC, Teddy JM, Postovit LM, Seftor EA, Seftor RE, Hendrix MJ and Kulesa PM: Reprogramming multipotent tumor cells with the embryonic neural crest micro-environment. Dev Dyn. 237:2657–2666. 2008. View Article : Google Scholar : PubMed/NCBI | |
Wang J, Emadali A, Le Bescont A, Callanan M, Rousseaux S and Khochbin S: Induced malignant genome reprogramming in somatic cells by testis-specific factors. Biochim Biophys Acta. 1809:221–225. 2011. View Article : Google Scholar : PubMed/NCBI | |
Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science. 318:1917–1920. 2007. View Article : Google Scholar : PubMed/NCBI | |
Okita K, Nakagawa M, Hyenjong H, Ichisaka T and Yamanaka S: Generation of mouse induced pluripotent stem cells without viral vectors. Science. 322:949–953. 2008. View Article : Google Scholar : PubMed/NCBI | |
Stadtfeld M, Nagaya M, Utikal J, Weir G and Hochedlinger K: Induced pluripotent stem cells generated without viral integration. Science. 322:945–949. 2008. View Article : Google Scholar : PubMed/NCBI | |
Aoi T, Yae K, Nakagawa M, et al: Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 321:699–702. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kim JB, Zaehres H, Wu G, Gentile L, et al: Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 454:646–650. 2008. View Article : Google Scholar : PubMed/NCBI | |
Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE and Melton DA: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 26:795–797. 2008. View Article : Google Scholar : PubMed/NCBI | |
Wernig M, Lengner CJ, Hanna J, et al: A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol. 26:916–924. 2008. View Article : Google Scholar : PubMed/NCBI | |
Sun N, Panetta NJ, Gupta DM, et al: Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA. 106:15720–15725. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zhou H, Wu S, Joo JY, et al: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 4:381–384. 2009. View Article : Google Scholar : PubMed/NCBI | |
Shi Y, Do JT, Desponts C, Hahm HS, Schöler HR and Ding S: A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2:525–528. 2008. View Article : Google Scholar : PubMed/NCBI | |
Woltjen K, Michael IP, Mohseni P, et al: piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 458:766–770. 2009. View Article : Google Scholar : PubMed/NCBI | |
Judson RL, Babiarz JE, Venere M and Blelloch R: Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 27:459–461. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P and Woltjen K: Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 458:771–775. 2009. View Article : Google Scholar : PubMed/NCBI | |
Seki T, Yuasa S, Oda M, et al: Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 7:11–14. 2010. View Article : Google Scholar : PubMed/NCBI | |
Warren L, Manos PD, Ahfeldt T, et al: Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 7:618–630. 2010. View Article : Google Scholar : PubMed/NCBI | |
Zhu S, Li W, Zhou H, et al: Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell. 7:651–655. 2010. View Article : Google Scholar : PubMed/NCBI | |
Li Z, Yang CS, Nakashima K and Rana TM: Small RNA-mediated regulation of iPS cell generation. EMBO J. 30:823–834. 2011. View Article : Google Scholar : PubMed/NCBI | |
Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R and Blelloch R: Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 29:443–448. 2011. View Article : Google Scholar : PubMed/NCBI | |
Li L, Connelly MC, Wetmore C, Curran T and Morgan JI: Mouse embryos cloned from brain tumors. Cancer Res. 63:2733–2736. 2003.PubMed/NCBI | |
Hochedlinger K, Blelloch R, Brennan C, Yamada Y, Kim M, Chin L and Jaenisch R: Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18:1875–1885. 2004. View Article : Google Scholar : PubMed/NCBI | |
Blelloch RH, Hochedlinger K, Yamada Y, et al: Nuclear cloning of embryonal carcinoma cells. Proc Natl Acad Sci USA. 101:13985–13990. 2004.PubMed/NCBI | |
Postovit LM, Margaryan NV, Seftor EA, et al: Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA. 105:4329–4334. 2008. View Article : Google Scholar : PubMed/NCBI | |
Utikal J, Maherali N, Kulalert W and Hochedlinger K: Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 122:3502–3510. 2009. View Article : Google Scholar : PubMed/NCBI | |
Carette JE, Pruszak J, Varadarajan M, Blomen VA and Gokhale S: Generation of iPSCs from cultured human malignant cells. Blood. 115:4039–4042. 2010. View Article : Google Scholar : PubMed/NCBI | |
Mathieu J, Zhang Z, Zhou W, Wang AJ and Heddleston JM: HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 71:4640–4652. 2011. View Article : Google Scholar : PubMed/NCBI | |
Allegrucci C, Rushton MD, Dixon JE, et al: Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol Cancer. 10:72011.PubMed/NCBI |